Related Experiment Video
Updated: Jul 1, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
[Intrusion of male epigenome regulators in somatic cancer cells]
Sophie Rousseaux1, Nicolas Reynoird, Jonathan Gaucher
1Equipe épigénétique et signalisation cellulaire. Inserm U823, Institut Albert Bonniot, Grenoble, F-38706 France. sophie.rousseaux@ujf-grenoble.fr
Abstract:
In healthy cells, several epigenetic mechanisms ensure structural and functional differentiation of the genome, and are necessary for the transcriptional silencing of most of the genome while a few genes, specific for each tissue type, are activated. Cell transformation disturbs this organization and induces the aberrant repression or activation of many genes. Whereas the transcriptional silencing of some critical cell regulators clearly contributes to cell malignant transformation, the oncogenic role of the illegitimate activation of tissue-specific genes in cancerous and pre-cancerous cells is still poorly known. This review aims to demonstrate the oncogenic potential of the illegitimate expression, in somatic cells, of genes, whose expression is normally restricted to male germ cells, encoding factors known as cancer testis or C/T, and particularly those involved in re-organizing the epigenome in these cells. The value of these genes, and of the factors they encode, in terms of cancer markers and promissing therapeutic targets will also be stressed.
Insights
Aberrant expression of cancer-testis (C/T) genes in somatic cells can drive cancer development. These genes, normally restricted to male germ cells, offer potential as cancer biomarkers and therapeutic targets.
Area of Science:
- Epigenetics
- Cancer Biology
- Genomics
Context:
- Epigenetic mechanisms regulate genome organization and gene expression in healthy cells.
- Cell transformation disrupts normal epigenetic organization, leading to aberrant gene activation or repression.
- The role of illegitimate tissue-specific gene activation in cancer is not fully understood.
Purpose:
- To review the oncogenic potential of illegitimate gene expression in somatic cells.
- To highlight cancer-testis (C/T) genes and their role in epigenome reorganization.
- To emphasize the value of C/T genes as cancer markers and therapeutic targets.
Summary:
- This review focuses on cancer-testis (C/T) genes, normally expressed only in male germ cells.
- Illegitimate expression of C/T genes in somatic cells, particularly those involved in epigenome modification, contributes to oncogenesis.
- The review explores the implications of C/T gene expression in cancer development and progression.
Impact:
- Demonstrates the oncogenic potential of aberrantly expressed C/T genes in cancer.
- Highlights C/T genes as promising biomarkers for cancer detection and diagnosis.
- Identifies C/T genes and their encoded factors as potential targets for novel cancer therapies.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Induced Pluripotent Stem Cells
Somatic cells are...
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Abnormal Proliferation
